Lupin Limited has informed the Exchange regarding a press release dated February 08, 2022, titled "Lupin Receives Approval from U.S. FDA for Arformoterol Tartrate Inhalation Solution 15 mcg (base)/2 ml. ".
Press Release Feb 08 2022
Filed with NSE ·
6ix hasn’t read this filing yet.
Earlier from Lupin
- Press Release Feb 03 2022
- Press Release Feb 01 2022
- Press Release Jan 27 2022
- Press Release Jan 19 2022
- Press Release Jan 07 2022
Later from Lupin
- Press Release Feb 09 2022
- Press Release Feb 17 2022
- Press Release Feb 23 2022
- Press Release Mar 01 2022
- Press Release Mar 03 2022
Follow Lupin into a list and get an email when it puts out news.
Follow Lupin